Lyra Therapeutics, Inc. entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co. to offer and sell shares of the Company's common stock for up to $50.0 million.
AI Assistant
LYRA THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.